Elizabeth M Grabowski, ARNP, BC-ADM, FAAN | |
4010 Dana Rd, Crestwood, KY 40014-9224 | |
(502) 895-2334 | |
Not Available |
Full Name | Elizabeth M Grabowski |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 4010 Dana Rd, Crestwood, Kentucky |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013964857 | NPI | - | NPPES |
78000387 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SM0705X | Clinical Nurse Specialist - Medical-surgical | 3001795 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Elizabeth M Grabowski, ARNP, BC-ADM, FAAN Po Box 6337, Louisville, KY 40206-0337 Ph: (502) 895-2334 | Elizabeth M Grabowski, ARNP, BC-ADM, FAAN 4010 Dana Rd, Crestwood, KY 40014-9224 Ph: (502) 895-2334 |
News Archive
A new website application for athletes called Dietary Analysis Tool for Athletes (D.A.T.A.) has been validated as accurately recording dietary intake based on the 24-hour recall method. "This tool offers sports dietitians and health professionals a new, quick alternative to analyze athletes' dietary intake," said Lindsay Baker, PhD, Principal Scientist, Gatorade Sports Science Institute.
A form of beta blocker, a drug commonly used to lower blood pressure and ward off repeat heart attacks, may provide the answer to preventing osteoporosis, said a Baylor College of Medicine researcher.
A new study on the smokeless tobacco product called moist snuff - placed between lip and gum - has led scientists in Minnesota to urge the tobacco industry to change manufacturing practices to reduce snuff's content of carcinogens.
Scioderm announced that the US Food and Drug Administration (FDA) has reviewed and allowed the investigational new drug (IND) application for SD-101 to proceed. SD-101 is a topical treatment being developed for the treatment of Epidermolysis Bullosa (EB).
Dr. Stanley Fineman, president of the American College of Allergy, Asthma and Immunology, (ACAAI) is available to comment on the School Access to Emergency Epinephrine Act, a federal bill introduced today that will help make epinephrine available in schools for the immediate treatment of anaphylactic reactions to food or other allergens.
› Verified 1 days ago